With steady sales, L-Nutra continues momentum and growth for the five-day Fasting Mimicking Diet
Los Angeles, Calif. – November 13, 2017 – In just over a year,L-Nutra, Inc. has established a new nutri-technology market with the launch of its flagship product, ProLon®, the first five-day Fasting Mimicking Diet (FMD™) scientifically proven and clinically tested to induce the health benefits of periodic fasting. ProLon is a Nutri-Revolution in healthcare as it represents the first product to be developed, tested preclinically and clinically, and launched for reversing biological aging and increasing Healthspan, the healthy part of our lives.
The company has also successfully sparked a global awareness movement supporting the benefits of fasting; ProLon has been featured by more than 200 top international media outlets and networks including CNN, BBC, FOX, WSJ, CBC, and the JAMA Network. Today more than 23,000 people have used ProLon, and over 3,200 healthcare providers and clinics have made ProLon available to their patients. In response, L-Nutra has rapidly expanded access to the product. Now ProLon is available for purchase online after the completion of a required health assessment, and over 1.5 million visitors have visited ProLon’s website for this purpose. In addition to the U.S. market, ProLon is now available in Italy, the United Kingdom, Poland, Ireland and Denmark, and the company plans to further expand to 14 new markets by the end of 2018.
To commemorate ProLon’s success, L-Nutra is also rolling out a fresh new look for the boxed, five-day meal program. This new product packaging offers a clean, simple design that underscores ProLon’s clinical inception and highlights ProLon’s tagline, “Rejuvenate, Regenerate, Revive.”
ProLon meals come in five convenient grab-and-go boxes (one for each day) that include proprietary plant-based energy bars, soups, a variety of snacks, drinks, and supplements to support healthy aging, cell regeneration, and fat-driven weight loss. The “fasting with food” program features meals ranging from 770 to 1,100 calories per day and is clinically proven to:Developed at the Longevity Institute at the University of Southern California’s Leonard Davis School of Gerontology in sponsorship by the National Institute for Aging (NIA) and the National Institute of Health (NIH), ProLon harnesses the latest in healthy life extension research in this innovative FMD program. Although water-only fasting can be challenging, it induces significant anti-aging changes, rejuvenation, and accelerated body healing. Scientists developed ProLon’s program to mimic these positive effects of fasting while mitigating its side effects by nourishing the body with natural food. The ProLon FMD diet is a five-day-only per month program and does not require alteration to lifestyle during the remaining days of the month.
- promote natural multi-system regeneration, including effects on a wide range of markers that contribute to aging, such as cholesterol, triglyceride, blood pressure, inflammation, and fasting blood glucose;
- maintain healthy levels of stem cells;
- help people lose an average of 5 pounds of fat and 1.2 inches of waist circumference while preserving lean body mass (muscle and bone); and
- provide the body with healthy, plant-based ingredients (free from any preservatives or chemicals) that provide the body with optimal nourishment including essential vitamins and amino acids, low-protein, low-carbohydrate, and high good fat ingredients to help the body protect and repair itself in a natural way.
“It’s been a very exciting journey and a privilege to launch a novel nutrition category that is unique in its scientific foundation and health effectiveness,” says Joseph Antoun MD, CEO of L-Nutra. “Now thousands of healthcare practitioners are offering ProLon to their patients, and we’ve also seen a significant increase in the number of customers proactively seeking ProLon themselves for metabolic and longevity reasons. After major global awareness campaigns, we are proud to see Fasting Mimicking recognized and adopted by key opinion leaders in healthcare. We look forward to bringing ProLon to additional markets and continuing to realize our ambitious goals of improving the lives of millions around the world.”
ProLon is intended for use by individuals who want to optimize their health and wellbeing, by overweight or obese individuals who want to manage their weight while protecting their lean body mass, and by people who have abnormal levels of biomarkers for aging and age-related conditions such as IGF-1, Cholesterol, C-reactive protein, and fasting blood glucose. For general info, please visit http://www.prolonfmd.com/.